Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer - John Nemunaitis; Laura Stanbery; Adam Walter; Adam Walter; Rodney Rocconi; Philip Stephens; Philip Stephens (Frontiers Media S.A., 2023)